用新技术管理精神障碍:Reel综合征中的无心脏起器,一个案例报告
P L Magliano1, F Scotto Di Uccio2, R Persico1
1Electrophysiology and Cardiac Pacing Unit, San Giovanni Bosco Hospital, Naples, Italy.
Pacing and clinical electrophysiology : PACE
|December 28, 2024
概括
里尔综合征是一种罕见的心脏起器脱落的原因,影响了一个患有唐氏综合征的患者. 治疗包括移除故障设备并植入无节奏系统.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 遗传学 是一个遗传学.
背景情况:
- 里尔综合征是心脏起器脱落的一个不常见的原因.
- 心脏起器的故障可能导致患者显著的发病率.
研究的目的:
- 报告一个患有唐氏综合征的患者患有Reel综合征的病例.
- 为了突出心脏起器由于Reel综合征导致的脱位的管理.
主要方法:
- 一个59岁的女性患有唐氏综合征,并使用双腔心脏起器的案例介绍.
- 基于异常的电气参数和脱落,诊断Reel综合征.
- 设备的扩展和无节奏系统的植入.
主要成果:
- 由于心脏起器故障,该患者经历了同性发作.
- 在2个月的随访中观察到异常的电气参数,这表明了Reel综合征.
- 成功管理,移除带系统并植入无心脏起器.
结论:
- 里尔综合征可能发生在需要起器的唐氏综合征患者中.
- 无节奏系统为管理心脏起器并发症提供了替代方案.
- 早期识别和适当的干预对于患者的治疗结果至关重要.
相关概念视频
Pulse rhythm
1.7K
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.7K
Mitral Stenosis III: Medical Management
539
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
539
Dysrhythmias VI: Management of Dysrhythmias
599
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
599
Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy V: Interprofessional Care
762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762


